In summary, this study confirms that AS-IV exerts multi-target protective effects against ischemic stroke by regulating the ROS-PINK1/Parkin pathway to improve mitochondrial function and inhibit neuronal apoptosis. The gene discussed is PRKN; the disease is ischemic stroke.